Successful treatment of relapsed/refractory Hodgkins lymphoma with nivolumab in a heavily pretreated patient with progressive disease after both autologous and allogeneic stem cell transplantation.
a Stem Cell Transplantation Unit, Hacettepe University Institute of Cancer , Ankara , Turkey.
Alma
A
Aslan
b Pozitron Nuclear Diagnostics Center , Ankara , Turkey.
Tülin
T
Aras
a Stem Cell Transplantation Unit, Hacettepe University Institute of Cancer , Ankara , Turkey.
Evren
E
Özdemir
D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D018450:Disease Progression; D019008:Drug Resistance, Neoplasm; D018380:Hematopoietic Stem Cell Transplantation; D006689:Hodgkin Disease / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000473:pathology*; D006801:Humans; D008297:Male; D058990:Molecular Targeted Therapy; D009367:Neoplasm Staging; D000077594:Nivolumab; D000072078:Positron Emission Tomography Computed Tomography; D012008:Recurrence; D019233:Retreatment; D014182:Transplantation, Autologous; D014184:Transplantation, Homologous
D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D000077594:Nivolumab